192 related articles for article (PubMed ID: 29097619)
1. Targeting the Lysosome for Cancer Therapy.
Towers CG; Thorburn A
Cancer Discov; 2017 Nov; 7(11):1218-1220. PubMed ID: 29097619
[TBL] [Abstract][Full Text] [Related]
2. A Unified Approach to Targeting the Lysosome's Degradative and Growth Signaling Roles.
Rebecca VW; Nicastri MC; McLaughlin N; Fennelly C; McAfee Q; Ronghe A; Nofal M; Lim CY; Witze E; Chude CI; Zhang G; Alicea GM; Piao S; Murugan S; Ojha R; Levi SM; Wei Z; Barber-Rotenberg JS; Murphy ME; Mills GB; Lu Y; Rabinowitz J; Marmorstein R; Liu Q; Liu S; Xu X; Herlyn M; Zoncu R; Brady DC; Speicher DW; Winkler JD; Amaravadi RK
Cancer Discov; 2017 Nov; 7(11):1266-1283. PubMed ID: 28899863
[TBL] [Abstract][Full Text] [Related]
3. REP1 Modulates Autophagy and Macropinocytosis to Enhance Cancer Cell Survival.
Choi J; Kim H; Bae YK; Cheong H
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28846638
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological inhibition of lysosomes activates the MTORC1 signaling pathway in chondrocytes in an autophagy-independent manner.
Newton PT; Vuppalapati KK; Bouderlique T; Chagin AS
Autophagy; 2015; 11(9):1594-607. PubMed ID: 26259639
[TBL] [Abstract][Full Text] [Related]
5. PDMP, a ceramide analogue, acts as an inhibitor of mTORC1 by inducing its translocation from lysosome to endoplasmic reticulum.
Ode T; Podyma-Inoue KA; Terasawa K; Inokuchi JI; Kobayashi T; Watabe T; Izumi Y; Hara-Yokoyama M
Exp Cell Res; 2017 Jan; 350(1):103-114. PubMed ID: 27865938
[TBL] [Abstract][Full Text] [Related]
6. Does mTORC1 inhibit autophagy at dual stages?: A possible role of mTORC1 in late-stage autophagy inhibition in addition to its known early-stage autophagy inhibition.
Ramaian Santhaseela A; Jayavelu T
Bioessays; 2021 Feb; 43(2):e2000187. PubMed ID: 33165974
[TBL] [Abstract][Full Text] [Related]
7. The lysosome: a crucial hub for AMPK and mTORC1 signalling.
Carroll B; Dunlop EA
Biochem J; 2017 Apr; 474(9):1453-1466. PubMed ID: 28408430
[TBL] [Abstract][Full Text] [Related]
8. Enzyme-based autophagy in anti-neoplastic management: From molecular mechanisms to clinical therapeutics.
Ajoolabady A; Aghanejad A; Bi Y; Zhang Y; Aslkhodapasandhukmabad H; Abhari A; Ren J
Biochim Biophys Acta Rev Cancer; 2020 Aug; 1874(1):188366. PubMed ID: 32339608
[TBL] [Abstract][Full Text] [Related]
9. mTORC1 and Nutrient Homeostasis: The Central Role of the Lysosome.
Rabanal-Ruiz Y; Korolchuk VI
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29534520
[TBL] [Abstract][Full Text] [Related]
10. PLK1 (polo like kinase 1) inhibits MTOR complex 1 and promotes autophagy.
Ruf S; Heberle AM; Langelaar-Makkinje M; Gelino S; Wilkinson D; Gerbeth C; Schwarz JJ; Holzwarth B; Warscheid B; Meisinger C; van Vugt MA; Baumeister R; Hansen M; Thedieck K
Autophagy; 2017 Mar; 13(3):486-505. PubMed ID: 28102733
[TBL] [Abstract][Full Text] [Related]
11. Nudix-type motif 2 contributes to cancer proliferation through the regulation of Rag GTPase-mediated mammalian target of rapamycin complex 1 localization.
Kwon O; Kwak D; Ha SH; Jeon H; Park M; Chang Y; Suh PG; Ryu SH
Cell Signal; 2017 Apr; 32():24-35. PubMed ID: 28089905
[TBL] [Abstract][Full Text] [Related]
12. Cucurbitacin E Induces Autophagy via Downregulating mTORC1 Signaling and Upregulating AMPK Activity.
Zha QB; Zhang XY; Lin QR; Xu LH; Zhao GX; Pan H; Zhou D; Ouyang DY; Liu ZH; He XH
PLoS One; 2015; 10(5):e0124355. PubMed ID: 25970614
[TBL] [Abstract][Full Text] [Related]
13. Lysosome identity crisis: Phosphoinositides and mTORC1 negotiate lysosomal behavior.
Mansat M; Botelho RJ
Mol Cell; 2024 Jan; 84(1):17-19. PubMed ID: 38181757
[TBL] [Abstract][Full Text] [Related]
14. Exploiting cancer vulnerabilities: mTOR, autophagy, and homeostatic imbalance.
Johnson CE; Tee AR
Essays Biochem; 2017 Dec; 61(6):699-710. PubMed ID: 29233879
[TBL] [Abstract][Full Text] [Related]
15. Autophagy induction targeting mTORC1 enhances Mycobacterium tuberculosis replication in HIV co-infected human macrophages.
Andersson AM; Andersson B; Lorell C; Raffetseder J; Larsson M; Blomgran R
Sci Rep; 2016 Jun; 6():28171. PubMed ID: 27302320
[TBL] [Abstract][Full Text] [Related]
16. The Contribution of Lysosomes to DNA Replication.
Merchut-Maya JM; Maya-Mendoza A
Cells; 2021 Apr; 10(5):. PubMed ID: 33946407
[TBL] [Abstract][Full Text] [Related]
17. Targeting autophagy in antitumor agent design: furthering the 'lysosomal love' strategy.
Sahni S; Kovacevic Z; Kalinowski DS; Huang M; Menezes S; Krishan S; Lane DJ; Jansson PJ; Richardson DR
Future Med Chem; 2016 May; 8(7):727-9. PubMed ID: 27149429
[No Abstract] [Full Text] [Related]
18. p53-mediated autophagic regulation: A prospective strategy for cancer therapy.
Tang J; Di J; Cao H; Bai J; Zheng J
Cancer Lett; 2015 Jul; 363(2):101-7. PubMed ID: 25896632
[TBL] [Abstract][Full Text] [Related]
19. Defective collagen proteostasis and matrix formation in the pathogenesis of lysosomal storage disorders.
Settembre C; Cinque L; Bartolomeo R; Di Malta C; De Leonibus C; Forrester A
Matrix Biol; 2018 Oct; 71-72():283-293. PubMed ID: 29870768
[TBL] [Abstract][Full Text] [Related]
20. Regulation of Akt-mTOR, ubiquitin-proteasome and autophagy-lysosome pathways in response to formoterol administration in rat skeletal muscle.
Joassard OR; Amirouche A; Gallot YS; Desgeorges MM; Castells J; Durieux AC; Berthon P; Freyssenet DG
Int J Biochem Cell Biol; 2013 Nov; 45(11):2444-55. PubMed ID: 23916784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
